Adipocytokine resistin correlates with oxidative stress and myocardial injury in patients undergoing cardiac surgery

European Journal of Cardio-thoracic Surgery

Volumn 46, Issue 4, 2014, Pages 729-736

  Laurikka, Antti ^a   Vuolteenaho, Katriina ^a   Toikkanen, Vesa ^b   Rinne, Timo ^b   Leppänen, Tiina ^a   Tarkka, Matti ^b   Laurikka, Jari ^b   Moilanen, Eeva ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adipocytokine; Cardiac surgery; Ischaemia reperfusion injury; Myocardial injury; Oxidative stress; Resistin

Indexed keywords

8 ISOPROSTANE; ACETYLSALICYLIC ACID; ADIPOCYTOKINE; ADIPONECTIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; COMPLEMENT FACTOR D; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; LEPTIN; MYELOPEROXIDASE; NITRIC ACID DERIVATIVE; RESISTIN; TROPONIN T; CYTOKINE;

AGED; ANESTHESIA; ANESTHESIA INDUCTION; AORTA CLAMPING; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DRUG TARGETING; FEMALE; FOLLOW UP; HEART MUSCLE INJURY; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; MALE; MYOCARDIAL DISEASE; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; SURGICAL APPROACH; BLOOD; COHORT ANALYSIS; INFLAMMATION; METABOLISM; PHYSIOLOGY;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; CORONARY ARTERY BYPASS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; RESISTIN;

EID: 84921938357     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt634     Document Type: Article

References (25)

1. Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med 2011;17:1391-401.
2. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97.
3. Smith CC, Yellon DM. Adipocytokines, cardiovascular pathophysiology and myocardial protection. Pharmacol Ther 2011;129:206-19.
4. Scotece M, Conde J, Vuolteenaho K, Koskinen A, Lopez V, Gomez-Reino J et al. Adipokines as drug targets in joint and bone disease. Drug Discov Today 2014;19:241-58.
5. Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006;91:4620-7.
6. Modan-Moses D, Prince A, Kanety H, Pariente C, Dagan O, Roller M et al. Patterns and prognostic value of troponin, interleukin-6, and leptin after pediatric open-heart surgery. J Crit Care 2009;24:419-25.
7. Smith CC, Dixon RA, Wynne AM, Theodorou L, Ong SG, Subrayan S et al. Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol 2010;299:H1265-70.
8. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005;11: 1096-103.
9. Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med 2010;14:1419-31.
10. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006;5:1.
11. Frankel DS, Vasan RS, D'Agostino RB Sr, Benjamin EJ, Levy D, Wang TJ et al. Resistin, adiponectin, and risk of heart failure the framingham offspring study. J Am Coll Cardiol 2009;53:754-62.
12. Weikert C, Westphal S, Berger K, Dierkes J, Mohlig M, Spranger J et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab 2008;93:2647-53.
13. Bostrom EA, Tarkowski A, Bokarewa M. Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta 2009;1793:1894-900.
14. Rothwell SE, Richards AM, Pemberton CJ. Resistin worsens cardiac ischaemia-reperfusion injury. Biochem Biophys Res Commun 2006;349: 400-7.
15. Gao J, Chang Chua C, Chen Z, Wang H, Xu X, C Hamdy R et al. Resistin, an adipocytokine, offers protection against acute myocardial infarction. J Mol Cell Cardiol 2007;43:601-9.
16. Smith CC, Lim SY, Wynne AM, Sivaraman V, Davidson SM, Mocanu MM et al. Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther 2011;16:63-71.
17. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004;109:784-9.
18. Liangos O, Domhan S, Schwager C, Zeier M, Huber PE, Addabbo F et al. Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation. PLoS One 2010;5:e13658.
19. Smith CC, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC, Yellon DM. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 2006;149:5-13.
20. Matsui H, Motooka M, Koike H, Inoue M, Iwasaki T, Suzuki T et al. Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sci 2007;80:672-80.
21. Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, Sakamoto T et al. Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. Circ J 2007;71:1703-9.
22. Kojima S, Funahashi T, Sakamoto T, Miyamoto S, Soejima H, Hokamaki J et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003;89:667.
23. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006;16:141-6.
24. Stahl GL, Xu Y, Hao L, Miller M, Buras JA, Fung M et al. Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 2003;162:449-55.
25. Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman Y, de Kleijn DP. The innate immune response in reperfused myocardium. Cardiovasc Res 2012;94:276-83.